You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

GlaxoSmithKline Sells Rabies and Tick Vaccines in $1.1 Billion Deal

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 686 Words

GALWAY, IRELAND--November 6, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--GlaxoSmithKline (NYSE:GSK) (GSK) (Brentford, England) has struck a 955 million-euro ($1.1 billion) deal to sell its two travel vaccines to Denmark's Bavarian Nordic (Kvistgaard, Denmark).

Within this article: Details vaccines sale, value of deal, GSK's vaccines division, new products and financial performance.

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $3.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00